NCT01828671

Brief Summary

Tortillas are a staple food in several cultures and are widely used to make tacos, burritos, and enchiladas. These foods are gaining a significant segment of the North American fast food and restaurant industry. From a health point of view, the addition of soy flour into corn tortillas will improve the nutritional profile of the tortillas and the presence of soy protein, dietary fibre and bioactive components has the potential to yield other health benefits. It is hypothesized that the addition of soy flour to corn tortillas will lower the glycemic index which could benefit those individuals with type 2 diabetes. The purpose of this research is to investigate whether different levels of soy flour in corn tortillas influences the glycemic response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 11, 2013

Completed
8 months until next milestone

Study Start

First participant enrolled

December 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

May 15, 2014

Status Verified

May 1, 2014

Enrollment Period

4 months

First QC Date

April 7, 2013

Last Update Submit

May 13, 2014

Conditions

Keywords

SoyCornFlourTortillaGlycemicGlucose,glycemic index

Outcome Measures

Primary Outcomes (1)

  • Blood glucose as measured via capillary sampling using glucometer

    Blood will be sampled via capillary finger prick at time-point 0, (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after the first bite of the tortillas or first sip of the glucose solution to determine blood glucose concentrations using a glucometer.

    0, 15, 30, 45, 60, 90 and 120 minutes

Study Arms (5)

Oral Glucose Solution 296 ml

ACTIVE COMPARATOR

Study Participants will consume oral glucose solution 296 mls. Blood will be sampled via capillary at time-point 0 (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after consumption to determine blood glucose concentrations using a glucometer. Per standard glycemic index testing protocols, this will be repeated at another visit.

Other: Corn TortillaOther: Low Soy Flour Corn TortillaOther: Moderate Soy Flour Corn TortillaOther: High Soy Flour Corn Tortilla

Corn Tortilla

ACTIVE COMPARATOR

Study Participants will consume 2 to 3.5 corn tortillas (12-15 cm in diameter each) with a total serving of 25 grams of available carbohydrate. Blood will be sampled via capillary at time-point 0 (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after consumption to determine blood glucose concentrations using a glucometer.

Other: Oral Glucose Solution 296 mls

Low Soy Flour Corn Tortilla

ACTIVE COMPARATOR

Study Participants will consume 2 to 3.5 tortillas (12-15 cm in diameter each) with a low amount of soy flour that is 25 grams of available carbohydrate. Blood will be sampled via capillary at time-point 0 (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after consumption to determine blood glucose concentrations using a glucometer.

Other: Oral Glucose Solution 296 mls

Moderate Soy Flour Corn Tortilla

ACTIVE COMPARATOR

Study Participants will consume 2 to 3.5 tortillas (12-15 cm in diameter each) with moderate amount of soy flour that has 25 grams of available carbohydrate. Blood will be sampled via capillary at time-point 0 (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after consumption to determine blood glucose concentrations using a glucometer.

Other: Oral Glucose Solution 296 mls

High Soy Flour Corn Tortilla

ACTIVE COMPARATOR

Study Participants will consume 2 to 3.5 tortillas (12-15 cm in diameter each) with a high amount soy flour that has 25 grams of available carbohydrate. Blood will be sampled via capillary at time-point 0 (before the product is consumed), and 15, 30, 45, 60, 90 and 120 minutes after consumption to determine blood glucose concentrations using a glucometer.

Other: Oral Glucose Solution 296 mls

Interventions

Should the participant be eligible to participate, they will be scheduled for two separate study visits to assess the glycemic response of the oral glucose solution.

Corn TortillaHigh Soy Flour Corn TortillaLow Soy Flour Corn TortillaModerate Soy Flour Corn Tortilla

Should the participant be eligible to participate, they will be scheduled for a study visit to assess the glycemic response of the corn tortillas.

Oral Glucose Solution 296 ml

Should the participant be eligible to participate, they will be scheduled for a single study visit to assess the glycemic response of corn tortillas with a low amount of soy flour.

Oral Glucose Solution 296 ml

Should the participant be eligible to participate, they will be scheduled for a single study visit to assess the glycemic response of corn tortillas with a moderate amount of soy flour.

Oral Glucose Solution 296 ml

Should the participant be eligible to participate, they will be scheduled for a single study visit to assess the glycemic response of corn tortillas with a high amount of soy flour.

Oral Glucose Solution 296 ml

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or female, greater or equal to 18 and less than or equal to 40 years of age;
  • Normal blood lipid profile (total cholesterol, LDL-cholesterol, HDL- cholesterol, triglycerides) and glycated hemoglobin \<6%;
  • Body mass index (BMI) of 20 to 30;
  • Stable regime for the past 3 months if taking vitamin and mineral/dietary/herbal supplements;
  • Agree not to eat soybeans (edamame) or soy-based foods, or consume soy or isoflavone supplements while participating in this study;
  • Willing to comply with the protocol requirements;
  • Willing to provide informed consent.

You may not qualify if:

  • Allergies to corn or soy flour or to corn or soy products;
  • Presence of a clinically diagnosed disease affecting the circulatory, respiratory, immune, skeletal, urinary, muscular, endocrine, digestive, nervous or reproductive system that requires medical treatment;
  • Taking any prescribed medication (with the exception of birth control) within the last 3 months, or taking supplements which affect glycemic control within the last 3 months;
  • Cigarette/cigar smoking, current or within the last 6 months;
  • Current (within the last 30 days) bacterial, viral or fungal infection, or taking over-the-counter medication within the past 72 h;
  • Pregnancy or lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Boniface General Hospital - Asper Clinical Research Institute

Winnipeg, Manitoba, R2H 2A6, Canada

Location

Related Publications (2)

  • Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G, Wolever TM. Glycaemic index methodology. Nutr Res Rev. 2005 Jun;18(1):145-71. doi: 10.1079/NRR2005100.

    PMID: 19079901BACKGROUND
  • Makelainen H, Anttila H, Sihvonen J, Hietanen RM, Tahvonen R, Salminen E, Mikola M, Sontag-Strohm T. The effect of beta-glucan on the glycemic and insulin index. Eur J Clin Nutr. 2007 Jun;61(6):779-85. doi: 10.1038/sj.ejcn.1602561. Epub 2006 Dec 6.

Related Links

MeSH Terms

Conditions

Callosities

Condition Hierarchy (Ancestors)

KeratosisSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Carla Taylor, PhD

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Principal Investigator

Study Record Dates

First Submitted

April 7, 2013

First Posted

April 11, 2013

Study Start

December 1, 2013

Primary Completion

April 1, 2014

Study Completion

May 1, 2014

Last Updated

May 15, 2014

Record last verified: 2014-05

Locations